Chairman's Comments: The Otolaryngology Drug Capsule, a popular part of the Academy's publication, the Perceived, is being transferred to otolaryngology and head and neck surgery at the request of the editors of the Journal. This capsule is sponsored by the Committee on Drugs—Otolaryngology and represents a continuing effort by its membership.
In this issue the clinical pharmacology of the useful antitumor drug, Bleomycin, is reviewed by Eric P. Lester, MD, and Gregory J. Matz, MD, from the University of Chicago.
Get full access to this article
View all access options for this article.
References
1.
BroughtonA: Clinical pharmacology of bleomycin following intravenous infusion as determined by radioimmunoassay. Cancer40: 27721977.
2.
KarakoffIH: Clinical pharmacologic and therapeutic studies of bleomycin given by continuous infusion. Cancer40: 2027, 1977.
3.
ChabnerBA: Clinical pharmacology of anticancer drugs. Semin Oncol4: 165, 1977.
4.
EinhornLHDonohueJ: Cis-diaminedi-chloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med87: 293, 1977.
5.
CarterSK: The chemotherapy of head and neck cancer. Semin Oncol4: 413, 1977.
